Form 4: Medicine Man Technologies Director Jonathan Berger Receives Stock Grant for Board Service

Jonathan Berger, a director at Medicine Man Technologies, received 66,159 shares of common stock valued at $54,250 for his service on the board.

Summary

• Jonathan Berger, a director of Medicine Man Technologies, Inc. (SHWZ), filed a Form 4 with the SEC on April 2, 2024.
• The filing reports a transaction that occurred on March 29, 2024, where Berger acquired 66,159 shares of common stock.
• These shares were granted as compensation for his service on the board of directors.
• The aggregate value of the shares was $54,250, based on the closing price of the common stock on the OTCQX Best Market on March 28, 2024.
• Following the transaction, Berger beneficially owns 448,877 shares of Medicine Man Technologies.
• Berger has also granted power of attorney to Philip McDermott, Christine Jones, and Zachary Weiss to handle SEC filings related to the company's securities.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (stock grant for board service) and doesn't contain any alarming or negative information. It's a neutral event with a slightly positive sentiment due to the alignment of interests between the director and shareholders.

Positives

• The stock grant aligns the director's interests with those of the shareholders.
• The power of attorney simplifies the process of SEC filings for the director.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• Stock grants to board members are a common form of compensation in publicly traded companies, including those in the cannabis industry.
• Comparing the size of this grant to similar companies like Curaleaf, Trulieve, or Green Thumb Industries would provide context on its relative value.
• The use of power of attorney for SEC filings is also a standard practice among corporate executives and directors.

Stakeholder Impact

• The stock grant could have a minor positive impact on shareholder sentiment by aligning the director's interests with theirs.
• The grant has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Form 4, Medicine Man Technologies, SHWZ, Jonathan Berger, Director, Stock Grant, Beneficial Ownership, SEC Filing, Power of Attorney